---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-005359"
form_type: "8-K"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2023-08-17T23:59:59+00:00"
generated_at: "2026-06-11T07:38:17.228521+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "medium"
source: SEC EDGAR
---

# Predictive Oncology CFO Bob Myers to resign Sept 30; Josh Blacher named Interim CFO

## Summary
- CFO Bob Myers notified resignation effective September 30, 2023, after nearly 12 years of service.
- Company entered consulting agreement with Danforth Advisors for interim CFO services.
- Josh Blacher of Danforth appointed Interim CFO; will serve as principal financial and accounting officer post-Transition Date.
- Blacher is Managing Partner at Columbus Circle Capital and has prior CFO roles at Galmed, Therapix, and Inmed Pharmaceuticals.

## SEC filing metadata
- accession: 0001171843-23-005359
- form_type: 8-K
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2023-08-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: medium
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184323005359/0001171843-23-005359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184323005359/f8k_081723.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-005359
- JSON: https://secwatch.observer/filing/0001171843-23-005359.json
- Plain text: https://secwatch.observer/filing/0001171843-23-005359.txt

## Key facts
- Executive change
  Josh Blacher was named as Interim Chief Financial Officer at Axe Compute Inc..
  - Action: named
  - Role: Interim Chief Financial Officer
  source text: Josh Blacher of Danforth, an experienced biotech executive who specializes in strategic finance and corporate development, has been named as the Company’s Interim Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446159/000117184323005359/0001171843-23-005359-index.htm
- Executive change
  Bob Myers resigned as Chief Financial Officer, Corporate Secretary and Compliance Officer at Axe Compute Inc..
  - Action: resigned
  - Role: Chief Financial Officer, Corporate Secretary and Compliance Officer
  source text: Bob Myers, the Chief Financial Officer, Corporate Secretary and Compliance Officer of Predictive Oncology Inc. (the "Company"), notified the Company of his intent to resign from the Company effective September 30, 2023 (the "Transition Date").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446159/000117184323005359/0001171843-23-005359-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.